Skip to main content
Journal cover image

Medical therapy of stone disease: from prevention to promotion of passage options.

Publication ,  Journal Article
Lipkin, M; Shah, O
Published in: Curr Urol Rep
January 2009

Medical therapy has been used for many years in the prevention of urinary stones. Medications directed at correcting urinary metabolic abnormalities responsible for promoting stone formation include thiazide diuretics, citrate salts, and allopurinol. All have proven to be efficacious. In addition, intake of citrate-rich juices, such as lemonade, may help to reduce urinary stone formation. More recently, there has been increasing interest in and use of medical therapy to aide in the passage of ureteral stones. Medical expulsive therapy (MET) has been shown to be cost effective compared with observation followed by treatment. Alpha-adrenergic receptor blockers are most commonly prescribed to promote passage of ureteral stones. They are able to facilitate stone passage, reduce time to passage, and decrease pain. Calcium-channel blockers also increase stone-passage rates. Steroids are useful adjuncts in MET.

Duke Scholars

Published In

Curr Urol Rep

DOI

EISSN

1534-6285

Publication Date

January 2009

Volume

10

Issue

1

Start / End Page

29 / 34

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Urinary Calculi
  • Hydrogen-Ion Concentration
  • Humans
  • Calcium Channel Blockers
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lipkin, M., & Shah, O. (2009). Medical therapy of stone disease: from prevention to promotion of passage options. Curr Urol Rep, 10(1), 29–34. https://doi.org/10.1007/s11934-009-0007-x
Lipkin, Michael, and Ojas Shah. “Medical therapy of stone disease: from prevention to promotion of passage options.Curr Urol Rep 10, no. 1 (January 2009): 29–34. https://doi.org/10.1007/s11934-009-0007-x.
Lipkin M, Shah O. Medical therapy of stone disease: from prevention to promotion of passage options. Curr Urol Rep. 2009 Jan;10(1):29–34.
Lipkin, Michael, and Ojas Shah. “Medical therapy of stone disease: from prevention to promotion of passage options.Curr Urol Rep, vol. 10, no. 1, Jan. 2009, pp. 29–34. Pubmed, doi:10.1007/s11934-009-0007-x.
Lipkin M, Shah O. Medical therapy of stone disease: from prevention to promotion of passage options. Curr Urol Rep. 2009 Jan;10(1):29–34.
Journal cover image

Published In

Curr Urol Rep

DOI

EISSN

1534-6285

Publication Date

January 2009

Volume

10

Issue

1

Start / End Page

29 / 34

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Urinary Calculi
  • Hydrogen-Ion Concentration
  • Humans
  • Calcium Channel Blockers